Drugmakers argue that they've pumped millions into research and so they can charge a lot more for drugs that used to be available cheaply. But experts find flaws in their logic. In other pharmaceutical news: the price of insulin and CVS' fourth-quarter profits.
from Kaiser Health News https://ift.tt/3bBFvDZ
February 13, 2020
Rose
Health News, Kaiser Health News
No comments
Related Posts:
‘We Sit In Our Own Pain, Thinking That Somehow We’re Broken’: Michelle Obama Opens Up About Miscarriage, IVFFormer first lady Michelle Obama talked about the silence surround fertility, miscarriages and IVF in an interview about her memoir, "Becoming." "I felt like I failed because I didn’t know how common miscarriages were because… Read More
‘Magical Thinking’ About Vitamin D’s Effect On Cancer And Fish Oil’s Effect On Heart Health Upended In Sweeping StudyAlthough both Vitamin D and fish oil drugs have gained popularity recently, a massive study found that healthy people who take the supplements do not lower cancer rates nor do they reduce the rate of major cardiovascular even… Read More
New Cholesterol Guidelines Call On Doctors To Tailor Treatments To Manage Risk For Each Individual PatientThe guidelines also recommend the use of two new kinds of drugs for those at the greatest danger of heart disease. from Kaiser Health News https://ift.tt/2qJkeC6 … Read More
Harmful Effects Of Childhood Trauma On Later Life Call For New Public Health Policies, Researchers SayA large study published in JAMA examines the wide-ranging health problems -- from depression to drug use -- that flare up in adulthood in people who experience early trauma compared to those who do not and raises ways to addr… Read More
‘This Isn’t Just My Lane. It’s My Highway’: Doctors Outraged Over NRA’s Suggestion That They Stay Out Of Gun DebateThe NRA's tweet saying doctors should "stay in their lane" over the gun control debate sparked furious, and sometimes graphic, responses from physicians who deal with gun shot victims frequently. "Do you have any idea how man… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment